loading page

POST-VACCINATION GIANT CELL HEPATITIS WITH AUTOIMMUNE HEMOLYTIC ANEMIA
  • Mai Abd El Salam,
  • Ahmad El-Hennawy,
  • Hanaa El-Karaksy
Mai Abd El Salam
Cairo University Childrens Hospital
Author Profile
Ahmad El-Hennawy
Cairo University Kasr Alainy Faculty of Medicine
Author Profile
Hanaa El-Karaksy
Cairo University Kasr Alainy Faculty of Medicine
Author Profile

Abstract

Giant cell hepatitis (GCH) with autoimmune hemolytic anemia (AIHA) is a rare entity in children. GCH is commonly described in infants. Vaccination has been incriminated as a trigger of development of AIHA in infants and children. However, vaccination has not been reported, till the time of writing the manuscript, to trigger the combination of Giant cell hepatitis with autoimmune hemolytic anemia. GCH with AIHA is usually fatal. Immunosuppressive treatment with conventional drugs offers some temporary response. We, herein, report a case of GCH with AIHA in a 4-month old male infant, following receipt of oral polio vaccine (OPV) and intramuscular diphtheria-tetanus-pertussis (DPT) vaccine. The patient was resistant to standard immunosuppressive combinations, and rescue therapy with Rituximab was used.